Cargando…

Probiotics in Children with Asthma

A type-2 immune response usually sustains wheezing and asthma in children. In addition, dysbiosis of digestive and respiratory tracts is detectable in patients with wheezing and asthma. Probiotics may rebalance immune response, repair dysbiosis, and mitigate airway inflammation. As a result, probiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciprandi, Giorgio, Tosca, Maria Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316460/
https://www.ncbi.nlm.nih.gov/pubmed/35883962
http://dx.doi.org/10.3390/children9070978
_version_ 1784754817826029568
author Ciprandi, Giorgio
Tosca, Maria Angela
author_facet Ciprandi, Giorgio
Tosca, Maria Angela
author_sort Ciprandi, Giorgio
collection PubMed
description A type-2 immune response usually sustains wheezing and asthma in children. In addition, dysbiosis of digestive and respiratory tracts is detectable in patients with wheezing and asthma. Probiotics may rebalance immune response, repair dysbiosis, and mitigate airway inflammation. As a result, probiotics may prevent asthma and wheezing relapse. There is evidence that some probiotic strains may improve asthma outcomes in children. In this context, the PROPAM study provided evidence that two specific strains significantly prevented asthma exacerbations and wheezing episodes. Therefore, oral probiotics could be used as add-on asthma therapy in managing children with asthma, but the choice should be based on documented evidence.
format Online
Article
Text
id pubmed-9316460
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93164602022-07-27 Probiotics in Children with Asthma Ciprandi, Giorgio Tosca, Maria Angela Children (Basel) Review A type-2 immune response usually sustains wheezing and asthma in children. In addition, dysbiosis of digestive and respiratory tracts is detectable in patients with wheezing and asthma. Probiotics may rebalance immune response, repair dysbiosis, and mitigate airway inflammation. As a result, probiotics may prevent asthma and wheezing relapse. There is evidence that some probiotic strains may improve asthma outcomes in children. In this context, the PROPAM study provided evidence that two specific strains significantly prevented asthma exacerbations and wheezing episodes. Therefore, oral probiotics could be used as add-on asthma therapy in managing children with asthma, but the choice should be based on documented evidence. MDPI 2022-06-29 /pmc/articles/PMC9316460/ /pubmed/35883962 http://dx.doi.org/10.3390/children9070978 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ciprandi, Giorgio
Tosca, Maria Angela
Probiotics in Children with Asthma
title Probiotics in Children with Asthma
title_full Probiotics in Children with Asthma
title_fullStr Probiotics in Children with Asthma
title_full_unstemmed Probiotics in Children with Asthma
title_short Probiotics in Children with Asthma
title_sort probiotics in children with asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316460/
https://www.ncbi.nlm.nih.gov/pubmed/35883962
http://dx.doi.org/10.3390/children9070978
work_keys_str_mv AT ciprandigiorgio probioticsinchildrenwithasthma
AT toscamariaangela probioticsinchildrenwithasthma